186 related articles for article (PubMed ID: 15941769)
21. Differences in hydroxylation and binding of Notch and HIF-1alpha demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1).
Wilkins SE; Hyvärinen J; Chicher J; Gorman JJ; Peet DJ; Bilton RL; Koivunen P
Int J Biochem Cell Biol; 2009 Jul; 41(7):1563-71. PubMed ID: 19401150
[TBL] [Abstract][Full Text] [Related]
22. Molecular evolution of the metazoan PHD-HIF oxygen-sensing system.
Rytkönen KT; Williams TA; Renshaw GM; Primmer CR; Nikinmaa M
Mol Biol Evol; 2011 Jun; 28(6):1913-26. PubMed ID: 21228399
[TBL] [Abstract][Full Text] [Related]
23. Cobalt induces hypoxia-inducible factor-1alpha (HIF-1alpha) in HeLa cells by an iron-independent, but ROS-, PI-3K- and MAPK-dependent mechanism.
Triantafyllou A; Liakos P; Tsakalof A; Georgatsou E; Simos G; Bonanou S
Free Radic Res; 2006 Aug; 40(8):847-56. PubMed ID: 17015263
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a second Arabidopsis thaliana prolyl 4-hydroxylase with distinct substrate specificity.
Tiainen P; Myllyharju J; Koivunen P
J Biol Chem; 2005 Jan; 280(2):1142-8. PubMed ID: 15528200
[TBL] [Abstract][Full Text] [Related]
25. A conserved family of prolyl-4-hydroxylases that modify HIF.
Bruick RK; McKnight SL
Science; 2001 Nov; 294(5545):1337-40. PubMed ID: 11598268
[TBL] [Abstract][Full Text] [Related]
26. Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases.
Cho EA; Song HK; Lee SH; Chung BH; Lim HM; Lee MK
J Cell Biochem; 2013 Apr; 114(4):864-73. PubMed ID: 23097160
[TBL] [Abstract][Full Text] [Related]
27. Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins.
Rajakumar A; Michael HM; Daftary A; Jeyabalan A; Gilmour C; Conrad KP
Placenta; 2008 Mar; 29(3):290-9. PubMed ID: 18222538
[TBL] [Abstract][Full Text] [Related]
28. An oxygen molecular sensor, the HIF prolyl 4-hydroxylase, in the marine protist Perkinsus olseni.
Leite RB; Brito AB; Cancela ML
Protist; 2008 Jul; 159(3):355-68. PubMed ID: 18539525
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-inducible factor prolyl 4-hydroxylases: common and specific roles.
Myllyharju J; Koivunen P
Biol Chem; 2013 Apr; 394(4):435-48. PubMed ID: 23324380
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger.
Choi KO; Lee T; Lee N; Kim JH; Yang EG; Yoon JM; Kim JH; Lee TG; Park H
Mol Pharmacol; 2005 Dec; 68(6):1803-9. PubMed ID: 16155211
[TBL] [Abstract][Full Text] [Related]
31. Preconditioning with cobalt chloride or desferrioxamine protects oligodendrocyte cell line (MO3.13) from tumor necrosis factor-alpha-mediated cell death.
Yao SY; Soutto M; Sriram S
J Neurosci Res; 2008 Aug; 86(11):2403-13. PubMed ID: 18438939
[TBL] [Abstract][Full Text] [Related]
32. Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH).
Flagg SC; Martin CB; Taabazuing CY; Holmes BE; Knapp MJ
J Inorg Biochem; 2012 Aug; 113():25-30. PubMed ID: 22687491
[TBL] [Abstract][Full Text] [Related]
33. The length of peptide substrates has a marked effect on hydroxylation by the hypoxia-inducible factor prolyl 4-hydroxylases.
Koivunen P; Hirsilä M; Kivirikko KI; Myllyharju J
J Biol Chem; 2006 Sep; 281(39):28712-20. PubMed ID: 16885164
[TBL] [Abstract][Full Text] [Related]
34. Oxygen tension regulates the expression of a group of procollagen hydroxylases.
Hofbauer KH; Gess B; Lohaus C; Meyer HE; Katschinski D; Kurtz A
Eur J Biochem; 2003 Nov; 270(22):4515-22. PubMed ID: 14622280
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a robust enzymatic assay for inhibitors of 2-oxoglutarate-dependent hydroxylases.
Kanelakis KC; Palomino HL; Li L; Wu J; Yan W; Rosen MD; Rizzolio MC; Trivedi M; Morton MF; Yang Y; Venkatesan H; Rabinowitz MH; Shankley NP; Barrett TD
J Biomol Screen; 2009 Jul; 14(6):627-35. PubMed ID: 19498081
[TBL] [Abstract][Full Text] [Related]
36. HIF prolyl 4-hydroxylases and their potential as drug targets.
Myllyharju J
Curr Pharm Des; 2009; 15(33):3878-85. PubMed ID: 19671043
[TBL] [Abstract][Full Text] [Related]
37. The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolyl-hydroxylases.
Acker T; Fandrey J; Acker H
Cardiovasc Res; 2006 Jul; 71(2):195-207. PubMed ID: 16740253
[TBL] [Abstract][Full Text] [Related]
38. Kinetic Analysis of HIF Prolyl Hydroxylases.
Koivunen P; Myllyharju J
Methods Mol Biol; 2018; 1742():15-25. PubMed ID: 29330786
[TBL] [Abstract][Full Text] [Related]
39. Selective inhibition of factor inhibiting hypoxia-inducible factor.
McDonough MA; McNeill LA; Tilliet M; Papamicaël CA; Chen QY; Banerji B; Hewitson KS; Schofield CJ
J Am Chem Soc; 2005 Jun; 127(21):7680-1. PubMed ID: 15913349
[TBL] [Abstract][Full Text] [Related]
40. Evolution of hypoxia and hypoxia-inducible factor asparaginyl hydroxylase regulation in chronic kidney disease.
Faivre A; Dissard R; Kuo W; Verissimo T; Legouis D; Arnoux G; Heckenmeyer C; Fernandez M; Tihy M; Rajaram RD; Delitsikou V; Le NA; Spingler B; Mueller B; Shulz G; Lindenmeyer M; Cohen C; Rutkowski JM; Moll S; Scholz CC; Kurtcuoglu V; de Seigneux S
Nephrol Dial Transplant; 2023 Sep; 38(10):2276-2288. PubMed ID: 37096392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
